HOME >> MEDICINE >> NEWS
New anti-angiogenic proteins discovered

Scientists at UCLA and Human Genome Sciences report discovery of two human proteins, METH-1 and METH-2, that inhibit blood vessel formation

More potent than endostatin, with potential for treating a range of cancer tumors

A team of scientists working at UCLA and Human Genome Sciences (NASDAQ: HGSI) discovered two human proteins that inhibit the formation of new blood vessels and have potential for treating cancer through suppression of tumor growth.

The two proteins, named METH-1 and METH-2, were shown to be much more active than endostatin in preventing blood vessel formation and may have applications in creating treatments for a broad range of tumor types.

The discovery of these two proteins and their anti-angiogenic activity is described in the August 13, 1999 issue of Journal of Biological Chemistry. The paper may be accessed at http://www.jbc.org .

The team, led by UCLA molecular biologist Luisa Iruela-Arispe, found that both METH-1 and METH-2 inhibited blood vessel formation in two standard biological model systems, the cornea pocket model and the chorioallontoic membrane model.

The ability of METH-1 and METH-2 to inhibit new blood vessel formation in the cornea pocket model was compared to that of both endostatin and thrombospondin, two other human proteins. The study showed that METH-1 was most potent in inhibiting blood vessel growth, followed by thrombospondin and endostatin.

A solid tumor cannot grow beyond the size of a pinhead unless it has an independent blood supply to deliver the oxygen and nutrients that the malignancy needs to advance and spread. To feed itself, a tumor develops its own blood supply, a process called angiogenesis. Researchers hope anti-angiogenic drugs can interrupt that process, thereby cutting off the blood supply to the tumor and, hopefully, killing it.
'"/>

Contact: Kate de Santis
kate_de_santis@hgsi.com
301-251-6003
Human Genome Sciences, Inc.
5-Aug-1999


Page: 1 2 3 4 5

Related medicine news :

1. Brain synapse formation linked to proteins, Stanford study finds
2. Scientists discover enzyme crucial to the transportation of proteins within cells
3. Uncoupling proteins in human heart
4. Lab studies show two proteins prevented progressive nerve cell loss in Parkinsons disease
5. Unexpected similarities between raindrops and proteins
6. Self-assembling proteins could help repair human tissue
7. New findings on nerve cell proteins show promise for reducing disability
8. C-reactive proteins do not predict early osteoarthritis
9. Two proteins may help prevent Alzheimers brain plaques
10. Cancers love-hate relationship with proteins offers new treatment window
11. Studies show Tim-3 proteins key to immune responses

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New anti angiogenic proteins discovered

(Date:8/3/2015)... ... August 03, 2015 , ... ... amputation , AUGUST 3, 2015 – Since winning a South by Southwest® (SXSW®) ... Impossible – an organization whose mission is to develop technology for the sake ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... ® and Navigant Center for Healthcare Research and Policy Analysis show widespread support ... of respondents said they agreed or strongly agreed that the controversial law passed ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its least visited ... untapped ground water aquifers, whose main outflow is at Ahjumawi Lava Springs, part ...
(Date:8/3/2015)... ... 03, 2015 , ... A July 13 article from The Daily Mail titled ... Natural Painkiller That Can Last 'For Five Weeks'" discusses the use of stem ... study showed that harvesting stem cell-rich bone marrow from the hip, known as bone ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dignity Health named Dr. Norris ... Hospital Emergency Room – Gilbert, opening in August. The new facility is licensed ... the West Valley. , “Dr. Baldwin is an excellent leader and will ensure ...
Breaking Medicine News(10 mins):Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3
(Date:8/3/2015)... Immune Pharmaceuticals, Inc. ("Immune") (NASDAQ: IMNP ... , will present live at VirtualInvestorConferences.com on August 6, ... 11:30AM EDT LINK:    http://tinyurl.com/aug6-pre-imnp ... investors are invited to ask the company questions in ... as the association,s "virtual trade booth." If attendees are ...
(Date:8/3/2015)... Colo., Aug. 3, 2015  Encision Inc. (PK:ECIA), a ... dangerous stray electrosurgical burns in minimally invasive surgery, today ... that ended June 30, 2015. The Company ... quarterly net loss of $213 thousand, or $(0.02) per ... million for a net loss of $202 thousand, or ...
(Date:8/3/2015)... , August 3, 2015 ... ) announced today that it has acquired ... Biotherapeutics Inc. for $300 million. With the acquisition, ... ophthalmic drops combining 0.6% povidone iodine (PVP-I) and ... the treatment of infectious conjunctivitis, an ocular surface ...
Breaking Medicine Technology:Immune Pharmaceuticals to Webcast Live at VirtualInvestorConferences.com August 6 2Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6
Cached News: